Clinical Trial

The OCT SORT-OUT VIII Study

Study acronym: OCT SORT-OUT
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare early vessel healing after implantation of SYNERGY drug eluting stent (DES) or BioMatrix NeoFlex DES at one and three months in two cohorts.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2014-09-26; most recent amendment 2025-12-29.
Status change: Recruiting → Active, Not Recruiting 2015-07-07
Trial Details
NCT Number NCT02253108
Lead Sponsor Aarhus University Hospital Skejby
Collaborators: Biosensors International, Boston Scientific Corporation
Conditions Coronary Artery Disease, Angina Pectoris, Myocardial Infarction
Enrollment 160 participants
Start Date 2014-05
Primary Completion 2015-04 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-02